Table 2.
Effect | Patients | Partners | ||||||
---|---|---|---|---|---|---|---|---|
β | 95% CI | t | P | β | 95% CI | t | P | |
PTSS-10 score | ||||||||
Age group 1 (≤ 57 years) | ||||||||
Actor effect | − .730 | − 1.030, − .430 | − 5.062 | < .001*** | − .705 | − .980, − .431 | − 5.345 | < .001*** |
Partner effect | .295 | − .044, .634 | 1.810 | .085 | − .250 | − .493, − .008 | − 2.145 | .044* |
− 2 log likelihood | 105.258 | |||||||
Bayes criterion | 116.471 | |||||||
Age group 2 (> 57, < 63 years) | ||||||||
Actor effect | − .497 | − .990, − .004 | − 2.108 | .049* | − .109 | − .662, .443 | − .413 | .684 |
Partner effect | − .200 | − .641, .240 | − .951 | .353 | .197 | − .422, .816 | .665 | .514 |
− 2 log likelihood | 129.108 | |||||||
Bayes criterion | 140.020 | |||||||
Age group 3 (≥ 63 years) | ||||||||
Actor effect | − .307 | − .708, .095 | − 1.587 | − .204 | − 1.013 | − 1.549, − .477 | − 3.928 | .001*** |
Partner effect | .234 | − .168, .637 | 1.213 | .239 | − .053 | − .588, .483 | − .204 | .840 |
− 2 log likelihood | 113.461 | |||||||
Bayes criterion | 124.674 |
Dependent variable: health-related quality of life (EQ-5D-3L, Rabin & de Charro, 2001); *≤ .05, **≤ .01, ***≤ .001